NCT05006118 - Pharmacokinetics and Excretion of Oral [14C]-Rodatristat Ethyl | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 23, 2021

Primary Completion Date

October 6, 2021

Study Completion Date

October 6, 2021

Conditions

Healthy

Interventions

DRUG

Radio-labeled rodatristat ethyl 600 mg

Single dose of rodatristat ethyl 600 mg as an oral suspension containing a mixture of \[12C\]-rodatristat ethyl and \[14C\]-rodatristat ethyl to contain approximately 600 microcuries (uCi) of radioactivity

Trial Locations (1)

53704

Covance Clinical Research Unit, Madison